| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characteristics of patients with severe asthma who experienced treatment failure with omalizumab
|
Akaba, Tomohiro
|
|
|
68 |
C |
p.
|
artikel
|
| 2 |
Chrysin prevents lipopolysaccharide-induced acute lung injury in mice by suppressing the IRE1α/TXNIP/NLRP3 pathway
|
Chen, Min
|
|
|
68 |
C |
p.
|
artikel
|
| 3 |
Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β
|
Agné, A.
|
|
|
68 |
C |
p.
|
artikel
|
| 4 |
Corrigendum to “Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway” [Pulm. Pharmacol. Therapeut. 65 (2020) 102000]
|
Chen, Min
|
|
|
68 |
C |
p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
68 |
C |
p.
|
artikel
|
| 6 |
Evaluation of efficacy of nebulized low molecular weight heparin as an adjunctive extra treatment for acute mild-moderate asthma attack; a randomized clinical trial study
|
Motamed, Hassan
|
|
|
68 |
C |
p.
|
artikel
|
| 7 |
Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-κB signaling pathway
|
Zou, Bo
|
|
|
68 |
C |
p.
|
artikel
|
| 8 |
Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis
|
Farmakis, Ioannis T.
|
|
|
68 |
C |
p.
|
artikel
|
| 9 |
The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant
|
Brightling, Chris
|
|
|
68 |
C |
p.
|
artikel
|
| 10 |
Treatment of pulmonary hypertension in patients with Hereditary Hemorrhagic Telangiectasia – A case series and systematic review
|
Abston, Eric
|
|
|
68 |
C |
p.
|
artikel
|
Tijdschrift beschrijving